U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07084480) titled 'Giant Cell Arteritis - Ways to Precision Medicine' on July 16.
Brief Summary: Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica and giant cell arteritis.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Giant Cell Arteritis
Polymyalgia Rheumatic (PMR)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Wuerzburg University Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....